Deva Holding AS | 销售成本

金融业

TRY

TRY 12.93B

现金及等价物

TRY 775.92M

TRY 991.13M

TRY 9.13B

TRY 6.43B

TRY 5.3B

股息收益率

0.18

TRY 820.88M

TRY 882.9M

EPS每股收益

TRY 2.92

股本和储备

TRY 5.79B

TRY 1.32B

债务利息支出

TRY 272.53M

TRY 559.97M

TRY 14.89B

TRY 583.98M

TRY 1.35B

TRY 964.87M

普通股股本

TRY 200.02M

6.55

TRY 2.32B

销售和管理费用

TRY 462.26M

贸易债权人

TRY 809.81M

应收帐款人

TRY 3.03B

	销售成本	更改		日
Akebia Therapeutics	USD 8.13M		2.41M	2025-03
Alaunos Therapeutics	USD 0		18K	2024-09
Avita Medical	AUD 3.47M		1.19M	2025-06
Deva Holding AS	TRY 991.13M		182.81M	2023-09
Ionis Pharmaceuticals	USD 2.34M		1.81M	2025-09
IQVIA Holdings	USD 3.24B		518M	2025-12
Moderna	USD 452M		245M	2025-12
Organon & Co	USD 745M		25M	2025-09
Revvity	USD 350.4M		26.05M	2025-12
Viatris	USD 2.39B		139.2M	2025-09
Xeris Pharmaceuticals	USD 13.71M		1.81M	2025-09

Deva Holding AS 销售成本 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.